Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Obesity

Weight loss drugs shouldn’t create ‘dependency culture’, says Health Secretary

Mr Sweeting said it was in “everyone’s interest to play their part” and avoid overloading the health system.

Evening Standard

Obesity in the U.S. Is Finally Declining. You Can (Probably) Thank Ozempic.

The medication shouldn't be this controversial.

Reason

The US has passed peak obesity, a new survey suggests. Is it the Ozempic effect?

One in eight American adults have tried weight loss drugs

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

As Weight-Loss Drugs Battle, Upstart Viking Therapeutics Threatens Eli Lilly, Novo Nordisk, Pfizer

Viking Therapeutics stock is on the rise as the battle to develop new weight-loss drugs heats up. Here's what's at stake for the pharma giants fighting for position.

Investors Business Daily

Eli Lilly Leads S&P Health Care Stocks With 1,241% Gain. But The Others Aren't Slackers.

Eli Lilly has gained markedly over the past decade. But it's not the only S&P 500 health care stock to notch a bullish gain.

Investors Business Daily

Ozempic’s cousin drug liraglutide is about to get cheaper. But how does it stack up?

Fourteen years ago, the older drug cousin of semaglutide (Ozempic and Wegovy) came onto the market. The drug, liraglutide, is sold under the brand names Victoza and Saxenda.

The Conversation

This Weight-Loss Stock Just Scored a New Street-High Price Target

Down 43% from all-time highs, Structure Therapeutics is a pre-revenue clinical-stage biopharma company that trades at a massive discount to consensus price target estimates.

Barchart

Read news from The Economist, FT, and more,
with one subscription

Study shows how new type of blood test identify kids at risk of diabetes

Scientists have developed a novel blood test that uses lipids to identify children who are more susceptible to obesity such as type 2 diabetes, liver, and heart disease? Read further on Dynamite News:

Dynamite News

BioAge Labs, An Obesity Newcomer And Eli Lilly Partner, Rises On Upsized IPO

BioAge Labs stock rose Thursday on the company's upsized IPO — reflecting enthusiasm for its approach to obesity treatments.

Investors Business Daily

Pregnancy obesity increases risk of autism, ADHD

An analysis of more than 3.6 million mother-child pairs has found children born to obese mothers have double the risk of developing autism and ADHD.

AAP

Fitness Influencer Banned From TikTok After Sparking Backlash For Harmful Dieting Advice

“What about all those influencers that promote obesity? Why aren’t their accounts being shut down?” The post Fitness Influencer Banned From TikTok After Sparking Backlash For Harmful Dieting Advice first appeared on Bored Panda.

Bored Panda

Novo Nordisk CEO takes aim at U.S. health system in Ozempic testimony

Novo Nordisk's CEO said the complexities of the U.S. healtchare system prevented access to $1,349 Wegovy.

Fortune

Severe obesity is on the rise in the US

Obesity is high and holding steady in the U.S. About 4 in 10 Americans have obesity overall and about 1 in 10 have severe obesity

The Independent UK

Analysts say market forces will lower cost of obesity drugs - Roll Call

Hearing on weight loss drug prices will feature CEO of Novo Nordisk and comes after threats to subpoena company executives.

Roll Call

Get all your
news in one place.

100’s of premium titles.
One news app.

The Guardian - UK

Health and productivity losses from obesity ‘far outstrip weight-loss jab costs’

Exclusive: £100bn-a-year cost of obesity to UK makes clear economic case for use of drugs such as Ozempic, says report

Barchart

Snag This Biotech Stock Before November, Here's Why

With Viking Therapeutics making a splash in the weight-loss drug arena, one analyst is encouraging investors to snap up the stock before a November catalyst.

The Independent UK

Council adopts ‘compassionate’ approach to obesity and rejects weight-loss goals

The council rejects the principle that a certain weight equals healthiness

The Guardian - UK

Mental health overtakes cancer and obesity as Britons’ biggest health worry

Ipsos survey asked people in 31 countries what they thought of their health and healthcare

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Novo Dives — And Corbus Crashes — On Psychiatric Side Effects Of Weight-Loss Drug

Novo Nordisk stock tumbled Friday — pulling Corbus into a steep dive — after its new obesity drug caused neuropsychiatric side effects.

The Independent UK

New blood test could be an early warning for child diabetes – study

Scientists say that testing for fatty acids could make it easier to identify children at risk of various conditions.

The Conversation

TRUTH in Labeling Act would heighten the warning for shoppers looking to cut sugar, salt and saturated fat intake

With rising rates of obesity in the U.S. and increasing attention being paid to the health harms of processed foods, it’s clear that far more could be done to help consumers make healthy food choices.

The Conversation

How we think about ‘obesity’ and body weight is changing. Here’s why

From doctors’ offices to family gatherings, larger-bodied people report being bombarded with unsolicited advice about their eating and exercise habits. The underlying message? They “just need to lose weight” to fix almost any health problem.

Medical Daily

Childhood obesity linked to schizophrenia in adulthood: study

Having more than the normal range of body mass index (BMI) in childhood could elevate the risk of developing schizophrenia in adulthood, the study revealed.

Salon

FDA hopes to fight obesity with labels

The agency plans to make a formal proposal in October

The Conversation

Ozempic, Wegovy, Rybelsus: Are we losing sight of overall health? Here’s what the science says

The craze for new drugs in the GLP-1 (Glucagon-like peptide 1) and GIP (Gastric inhibitory polypeptide) analogue class, better known under the trade names Ozempic and Wegovy, is remarkable, but it’s not totally unprecedented in the history of pharmaceutical blockbusters.

1 … 3 4 5 6

People

Lars Fruergaard Jørgensen

10 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.